IL-13Rα2 Status Predicts GB-13 (IL13.E13K-PE4E) Efficacy in High-Grade Glioma

por Rechberger, Julian S., Porath, Kendra A., Zhang, Liang, Nesvick, Cody L., Schrecengost, Randy S., Sarkaria, Jann N., Daniels, David J.
Publicado 2022

Convection enhanced delivery of EGFR targeting antibody-drug conjugates Serclutamab talirine and Depatux-M in glioblastoma patient-derived xenografts

por Porath, Kendra A, Regan, Michael S, Griffith, Jessica I, Jain, Sonia, Stopka, Sylwia A, Burgenske, Danielle M, Bakken, Katrina K, Carlson, Brett L, Decker, Paul A, Vaubel, Rachael A, Dragojevic, Sonja, Mladek, Ann C, Connors, Margaret A, Hu, Zeng, He, Lihong, Kitange, Gaspar J, Gupta, Shiv K, Feldsien, Thomas M, Lefebvre, Didier R, Agar, Nathalie Y R, Eckel-Passow, Jeanette E, Reilly, Edward B, Elmquist, William F, Sarkaria, Jann N
Publicado 2022